𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma

✍ Scribed by Masanori Fujii; Nobukazu Fujimoto; Akio Hiraki; Kenichi Gemba; Keisuke Aoe; Shigeki Umemura; Hideki Katayama; Nagio Takigawa; Katsuyuki Kiura; Mitsune Tanimoto; Takumi Kishimoto

Book ID
114703155
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
301 KB
Volume
103
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Aberrant promoter methylation in pleural
Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion
✍ Hideki Katayama; Akio Hiraki; Keisuke Aoe; Keiichi Fujiwara; Keitaro Matsuo; Tad πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 108 KB

## Abstract Accumulating evidence implicates epigenetic changes such as hypermethylation in carcinogenesis. We investigated whether DNA methylation of 5 tumor suppressor genes in pleural fluid samples could aid in diagnosis of malignant effusion. In samples from 47 patients with malignant pleural e

Downregulated microRNAs in the different
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
✍ Gretchen V. Gee; Devin C. Koestler; Brock C. Christensen; David J. Sugarbaker; D πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 401 KB

## Abstract Malignant pleural mesothelioma (MPM) is a rapidly fatal disease whose diagnosis, particularly through less invasive techniques such as analysis of pleural effusion, can be challenging. Currently, a commercially available diagnostic test based on microRNA (miRNA) expression patterns is p

Accuracy of pleural biopsy using thoraco
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma
✍ Laurent Greillier; Arnaud Cavailles; Anne Fraticelli; Arnaud Scherpereel; Fabric πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 72 KB

## Abstract ## BACKGROUND. Promising results with trimodality therapy combining surgery, chemotherapy, and radiotherapy have been obtained in the management of patients with malignant pleural mesothelioma (MPM). However, the histologic subtype has to be taken into account because of its influence